Back

After peripheral endovascular therapy, DAPT remains the preferred option over dual-pathway antithrombotic therapy: con.

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Great Debate: antithrombotic therapeutic dilemmas in PAD – dual antiplatelet or dual-pathway antithrombotic therapy? Peripheral Vascular and Cerebrovascular Disease ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Marianne Brodmann

Medical University of Graz, Graz (Austria)

2 More presentations in this session

Presentation thumbnail
After peripheral endovascular therapy, DAPT remains the preferred option over dual-pathway antithrombotic therapy: pro.
Professor C. Heiss (Guildford, GB)
Slides Video
Presentation thumbnail
Great Debate: antithrombotic therapeutic dilemmas in PAD – dual antiplatelet or dual-pathway antithrombotic therapy? – discussion.
Professor I. Baumgartner (Bern, CH)
Slides Video

Access the full session

Session thumbnail
Great Debate: antithrombotic therapeutic dilemmas in PAD – dual antiplatelet or dual-pathway antithrombotic therapy?
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources